Patents by Inventor Shawna HENGEL

Shawna HENGEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF QUANTIFYING ANTI-CD40 ANTIBODIES
    Publication number: 20240142463
    Abstract: The present disclosure relates to methods of determining the amount of an anti-CD40 antibody in a sample. The present disclosure also relates to anti-CD40 antibody signature analytic peptides.
    Type: Application
    Filed: November 21, 2023
    Publication date: May 2, 2024
    Inventors: Shawna Hengel, Steve Alley, Barry Jones
  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER
    Publication number: 20230330241
    Abstract: Methods for using anti-LIV1 antibodies and antibody-drug conjugates, including anti-LIV1 antibody-drug conjugates, to inhibit proliferation of a cell, such as a LIV1-expressing cell, as well as for the treatment of cancers, such as, e.g., LIV1-associated solid tumors and breast cancer (e.g., locally advanced or metastatic breast cancer), are provided.
    Type: Application
    Filed: February 17, 2023
    Publication date: October 19, 2023
    Inventors: Emily STEVENS, Hong LI, William HANLEY, Phillip GARFIN, Shawna HENGEL
  • DOUBLE-DIGESTION ASSAY FOR ANALYZING LIGAND-DRUG CONJUGATES
    Publication number: 20230022980
    Abstract: Methods for analysis of a glucuronide ligand-drug conjugate are provided.
    Type: Application
    Filed: September 2, 2020
    Publication date: January 26, 2023
    Inventors: Shawna Hengel, Michael Raymond Mylott, Jr., Michael Paul Waldron, Jr., James Aloysius Creegan
  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER
    Publication number: 20210030885
    Abstract: Methods for using anti-LIV1 antibodies and antibody-drug conjugates, including anti-LIV1 antibody-drug conjugates, to inhibit proliferation of a cell, such as a LIV1-expressing cell, as well as for the treatment of cancers, such as, e.g., LIV1-associated solid tumors and breast cancer (e.g., locally advanced or metastatic breast cancer), are provided.
    Type: Application
    Filed: July 21, 2020
    Publication date: February 4, 2021
    Inventors: Emily STEVENS, Hong LI, William HANLEY, Phillip GARFIN, Shawna HENGEL